Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome

Santhosh A. Upadhyaya; Rose B. McGee; Breelyn A. Wilky; Alberto Broniscer

doi:10.1002/pbc.27030

Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome

Santhosh A. Upadhyaya, Rose B. McGee, Breelyn A. Wilky, Alberto Broniscer

Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Malignant progression of a benign or low-grade tumor in individuals with germline alteration of SMARCB1 gene is not well characterized. In a family in which two carrier children had germline SMARCB1 mutations and atypical teratoid rhabdoid tumor, we report malignant progression of a nerve sheath tumor over a 7-year period in an affected adult family member. Prompt identification of the germline SMARCB1 alteration and the resultant rhabdoid tumor predisposition syndrome can help guide genetic counseling and surveillance in affected family members.

Original language	English (US)
Article number	e27030
Journal	Pediatric Blood and Cancer
Volume	65
Issue number	7
DOIs	https://doi.org/10.1002/pbc.27030
State	Published - Jul 2018

Keywords

NRAS mutation
malignant progression
peripheral nerve sheath tumor
rhabdoid tumor predisposition syndrome

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.27030

Fingerprint Dive into the research topics of 'Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome'. Together they form a unique fingerprint.

Cite this

@article{576baccb01e94268872315bc1eb9728f,

title = "Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome",

abstract = "Malignant progression of a benign or low-grade tumor in individuals with germline alteration of SMARCB1 gene is not well characterized. In a family in which two carrier children had germline SMARCB1 mutations and atypical teratoid rhabdoid tumor, we report malignant progression of a nerve sheath tumor over a 7-year period in an affected adult family member. Prompt identification of the germline SMARCB1 alteration and the resultant rhabdoid tumor predisposition syndrome can help guide genetic counseling and surveillance in affected family members.",

keywords = "NRAS mutation, malignant progression, peripheral nerve sheath tumor, rhabdoid tumor predisposition syndrome",

author = "Upadhyaya, {Santhosh A.} and McGee, {Rose B.} and Wilky, {Breelyn A.} and Alberto Broniscer",

note = "Funding Information: The authors gratefully acknowledge Dr. Susana Raimondi, Department of Pathology, St. Jude Children's Research Hospital, for providing the artwork for SMARCB1 FISH and Dr. Vani Shanker for editing the manuscript. Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2018",

month = jul,

doi = "10.1002/pbc.27030",

language = "English (US)",

volume = "65",

journal = "Medical and Pediatric Oncology",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "7",

}

TY - JOUR

T1 - Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome

AU - Upadhyaya, Santhosh A.

AU - McGee, Rose B.

AU - Wilky, Breelyn A.

AU - Broniscer, Alberto

N1 - Funding Information: The authors gratefully acknowledge Dr. Susana Raimondi, Department of Pathology, St. Jude Children's Research Hospital, for providing the artwork for SMARCB1 FISH and Dr. Vani Shanker for editing the manuscript. Publisher Copyright: © 2018 Wiley Periodicals, Inc. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2018/7

Y1 - 2018/7

N2 - Malignant progression of a benign or low-grade tumor in individuals with germline alteration of SMARCB1 gene is not well characterized. In a family in which two carrier children had germline SMARCB1 mutations and atypical teratoid rhabdoid tumor, we report malignant progression of a nerve sheath tumor over a 7-year period in an affected adult family member. Prompt identification of the germline SMARCB1 alteration and the resultant rhabdoid tumor predisposition syndrome can help guide genetic counseling and surveillance in affected family members.

AB - Malignant progression of a benign or low-grade tumor in individuals with germline alteration of SMARCB1 gene is not well characterized. In a family in which two carrier children had germline SMARCB1 mutations and atypical teratoid rhabdoid tumor, we report malignant progression of a nerve sheath tumor over a 7-year period in an affected adult family member. Prompt identification of the germline SMARCB1 alteration and the resultant rhabdoid tumor predisposition syndrome can help guide genetic counseling and surveillance in affected family members.

KW - NRAS mutation

KW - malignant progression

KW - peripheral nerve sheath tumor

KW - rhabdoid tumor predisposition syndrome

UR - http://www.scopus.com/inward/record.url?scp=85043351329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043351329&partnerID=8YFLogxK

U2 - 10.1002/pbc.27030

DO - 10.1002/pbc.27030

M3 - Article

C2 - 29512865

AN - SCOPUS:85043351329

VL - 65

JO - Medical and Pediatric Oncology

JF - Medical and Pediatric Oncology

SN - 1545-5009

IS - 7

M1 - e27030

ER -

Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this